Summary
Updated Aug 30, 2026
Peggy Hwan Hebard is Director of Rithm Capital Corp. (RITM). 2 SEC Form 4 filings on record, most recently on 25 August 2026. Most recent open-market trade: sold $148K of RITM on 25 August 2026. Lifetime open-market sales: $148K.
Recent Transactions
2Every recent SEC Form 4 transaction Peggy Hwan Hebard has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Peggy Hwan Hebard files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael Nierenberg - $3.32M of RITM open-market activity in the last 12 months
- David Saltzman - $748K of RITM open-market activity in the last 12 months
- David Zeiden - $307K of RITM open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Peggy Hwan Hebard?
Peggy Hwan Hebard is a corporate insider, tracked as Director of Rithm Capital Corp. (RITM). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Peggy Hwan Hebard submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Peggy Hwan Hebard been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($148K) across all tracked filings.
Where can I see all of Peggy Hwan Hebard's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Peggy Hwan Hebard and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
